Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsIV (INFUSION)Standard

RAXIBACUMAB

RAXIBACUMAB

Standard Dose
1700MG/34ML (50MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview RAXIBACUMAB is listed in Drugs@FDA under application 125349 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient RAXIBACUMAB Form and strength INJECTABLE; IV (INFUSION) - 1700MG/34ML (50MG/ML) Sponsor HUMAN GENOME SCIENCES INC.

Structured Monograph

Clinical summary

Approval overview RAXIBACUMAB is listed in Drugs@FDA under application 125349 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient RAXIBACUMAB Form and strength INJECTABLE; IV (INFUSION) - 1700MG/34ML (50MG/ML) Sponsor HUMAN GENOME SCIENCES INC. Submission history Latest submission status date: 2021-06-02 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.